FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: A meta-analysis

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 7, 2010, Pages 1007-1022

  Pan, Lingling ^a   Han, Yuan ^a   Sun, Xiaoguang ^a   Liu, Jianjun ^a   Gang, Huang ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

CT; Meta analysis; MRI; PET; Recurrent and or metastatic breast cancer; SMM; US

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; IODINATED CONTRAST MEDIUM; MEDRONATE TECHNETIUM TC 99M; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NONIONIC CONTRAST MEDIUM; SHU 508; SONOVUE; TETROFOSMIN TC 99M; THALLIUM CHLORIDE TL 201;

AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ECHOMAMMOGRAPHY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; META ANALYSIS; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 77953232665     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0746-6     Document Type: Article

References (90)

1. N Aide V Huchet O Switsers N Heutte 2007 Influence of CA 15-3 blood level and doubling time on diagnostic performances of 18F-FDG PET in breast cancer patients with occult recurrence Nucl Med Commun 28 4 267 272 17325589
2. American Cancer Society (2002) Breast cancer facts and figures. American Cancer Society, Atlanta, GA, pp 9-10
3. WG Armington HR Harnsberger AG Osborn AR Seay 1987 Radiographic evaluation of brachial plexopathy Am J Neuroradiol 8 2 361 367 1:STN:280:DyaL2s7otFersw%3D%3D 3031969
4. E Bäz H Madjar C Reuss M Vetter 2000 The role of enhanced Doppler ultrasound in differentiation of benign vs. malignant scar lesion after breast surgery for malignancy Ultrasound Obstet Gynecol 15 5 377 382 10976477
5. P Belli G Pastore M Romani D Terribile A Canadè 2002 Role of magnetic resonance imaging in the diagnosis of recurrence after breast conserving therapy Rays 27 4 241 257 12696288
6. JA Berlin 1997 Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group Lancet 350 9072 185 186 1:STN:280:DyaK2szptlOmtA%3D%3D 9250191
7. JH Bilbey RG Lamond RF Mattrey 1994 MR imaging of disorders of the brachial plexus J Magn Reson Imag 4 1 13 18 1:STN:280:DyaK2c7pvVCqsA%3D%3D
8. V Bongers C Perre P de Hooge 2004 The use of scintimammography for detecting the recurrence of loco-regional breast cancer: histopathologically proven results Nucl Med Commun 25 2 145 149 15154703
9. JN Bruneton E Caramella M Héry D Aubanel 1986 Axillary lymph node metastases in breast cancer: preoperative detection with US Radiology 158 2 325 326 1:STN:280:DyaL28%2FpsFWlsw%3D%3D 3510440
10. Cancer Research Campaign (1996) Breast cancer. Cancer Research Campaign, UK, fact sheet
11. JB Cwikla JR Buscombe SP Parbhoo SM Kelleher 1998 Use of 99Tcm-MIBI in the assessment of patients with suspected recurrent breast cancer Nucl Med Commun 19 7 649 655 1:STN:280:DyaK1M%2FntVCmtQ%3D%3D 9853345
12. C De Cicco G Trifirò S Baio ML Sierra M Pizzamiglio 2004 Clinical utility of 99mTc-Sestamibi scintimammography in the management of equivocal breast lesions Cancer Biother Radiopharm 19 5 621 626 15650455
13. HJ de Verdier PM Colletti MR Terk 1993 MRI of the brachial plexus: a review of 51 cases Comput Med Imaging Graph 17 1 45 50 8448763
14. JJ Deeks 2001 Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests BMJ 323 7305 157 162 1:STN:280:DC%2BD3MvhsVSlsQ%3D%3D 11463691
15. F Dehdashti JE Mortimer BA Siegel LK Griffeth 1995 Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays J Nucl Med 36 10 1766 1774 1:STN:280: DyaK28%2FgslKhsQ%3D%3D 7562040
16. DD Dershaw B McCormick MP Osborne 1992 Detection of local recurrence after conservative therapy for breast carcinoma Cancer 70 2 493 496 1:STN:280:DyaK38zhsFWmtA%3D%3D 1617598
17. WL Devillé PD Bezemer LM Bouter 2000 Publications on diagnostic test evaluation in family medicine journals: an optimal search strategy J Clin Epidemiol 53 1 65 69 10693905
18. WL Devillé F Buntinx LM Bouter VM Montori 2002 Conducting systematic reviews of diagnostic studies: didactic guidelines BMC Med Res Methodol 2 9 12097142
19. PJ Drew MJ Kerin LW Turnbull M Imrie 1998 Routine screening for local recurrence following breast-conserving therapy for cancer with dynamic contrast-enhanced magnetic resonance imaging of the breast Ann Surg Oncol 5 3 265 270 1:STN:280:DyaK1c3mvVKntA%3D%3D 9607630
20. WB Eubank DA Mankoff J Takasugi H Vesselle 2001 18Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer J Clin Oncol 19 15 3516 3523 1:STN:280: DC%2BD3MvjtlOmtQ%3D%3D 11481358
21. WB Eubank DA Mankoff HJ Vesselle JF Eary 2002 Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET Radiographics 22 1 5 17 11796893
22. WB Eubank D Mankoff M Bhattacharya J Gralow 2004 Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer Am J Roentgenol 183 2 479 486
23. ER Fisher S Anderson E Tan-Chiu B Fisher 2001 Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06 Cancer 91 8 Suppl 1679 1687 1:STN:280: DC%2BD3M3hvFWnsw%3D%3D 11309768 (Pubitemid 32319246)
24. Fleiss JL, Levin B, Paik MC (2003) The comparison of proportions from several independent samples: estimation of the marginal mean proportion. In: Fleiss JL, Levin B, Paik MC (eds) Statistical methods for rates and proportions, 3rd edn. Wiley, New Jersey, pp 212-217
25. BJ Fueger WA Weber A Quon TL Crawford 2005 Performance of 2-deoxy-2-[F-18]fluoro-d-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients Mol Imag Biol 7 5 369 376
26. HJ Gallowitsch E Kresnik J Gasser G Kumnig I Igerc 2003 F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging Invest Radiol 38 5 250 256 12750613
27. R Gilles JM Guinebretière LG Shapeero A Lesnik 1993 Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients Radiology 188 2 473 478 1:STN:280: DyaK3szhslyrtg%3D%3D 8327700
28. GW Goerres SC Michel MK Fehr AH Kaim 2003 Follow-up of women with breast cancer: comparison between MRI and FDG PET Eur Radiol 13 7 1635 1644 12835979
29. C Hagay PJ Cherel CE de Maulmont MM Plantet 1996 Contrast-enhanced CT: value for diagnosing local breast cancer recurrence after conservative treatment Radiology 200 3 631 638 1:STN:280:DyaK28zkslyhug%3D%3D 8756908
30. PB Hathaway DA Mankoff KR Maravilla MM Austin-Seymour 1999 Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience Radiology 210 3 807 814 1:STN:280:DyaK1M3itlyqsA%3D%3D 10207485
31. L Hatteville C Mahe C Hill 2002 Prediction of the long-term survival in breast cancer patients according to the present oncological status Stat Med 21 16 2345 2354 12210619
32. AR Haug GP Schmidt A Klingenstein V Heinemann 2007 F-18-fluoro-2- deoxyglucose positron emission tomography/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers J Comput Assist Tomogr 31 4 629 634 17882045
33. SH Heywang-Köbrunner A Schlegel R Beck T Wendt 1993 Contrast-enhanced MRI of the breast after limited surgery and radiation therapy J Comput Assist Tomogr 17 6 891 900 8227574
34. 2 index? Psychol Methods 11 2 193 206 16784338
35. CR Isasi RM Moadel MD Blaufox 2005 A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases Breast Cancer Res Treat 90 105 112 1:CAS:528:DC%2BD2MXivVKhsrc%3D 15803356
36. C Kamby I Vejborg B Kristensen LO Olsen 1988 Metastatic pattern in recurrent breast cancer. Special reference to intrathoracic recurrences Cancer 62 10 2226 2233 1:STN:280:DyaL1M%2FivVWjtw%3D%3D 3179937
37. EM Kamel MT Wyss MK Fehr GK von Schulthess 2003 [18F]-Fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer J Cancer Res Clin Oncol 129 3 147 153 12712329
38. CH Kao SJ Wang TJ Liu 1994 The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses Eur J Nucl Med 21 5 432 436 1:STN:280:DyaK2czktFarug%3D%3D 8062849
39. CH Kao JF Hsieh SC Tsai YJ Ho 2000 Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases Anticancer Res 20 3B 2189 2192 1:CAS:528: DC%2BD3cXlvFCqs70%3D 10928175
40. I Khalkhali J Cutrone I Mena L Diggles 1995 Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up J Nucl Med 36 10 1784 1789 1:STN:280:DyaK28%2FgslKhtA%3D%3D 7562043
41. JL Khatcheressian AC Wolff TJ Smith E Grunfeld 2006 American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting J Clin Oncol 24 31 5091 5097 17033037
42. TS Kim WK Moon DS Lee JK Chung 2001 Fluorodeoxyglucose positron emission tomography for detection of recurrent or metastatic breast cancer World J Surg 25 7 829 834 1:STN:280:DC%2BD3MrisVCquw%3D%3D 11572019
43. JB Kneeland GM Kellman WD Middleton JD Cates 1987 Diagnosis of diseases of the supraclavicular region by use of MR imaging Am J Roentgenol 148 6 1149 1151 1:STN:280:DyaL2s3gvFGkug%3D%3D
44. M Lamuraglia N Lassau JR Garbay MC Mathieu 2005 Doppler US with perfusion software and contrast medium injection in the early evaluation of radiofrequency in breast cancer recurrences: a prospective phase II study Eur J Radiol 56 3 376 381 16005593 [Epub 2005 Jul 7] (Pubitemid 41659388)
45. ML Landheer MG Steffens JH Klinkenbijl AH Westenberg 2005 Value of fluorodeoxyglucose positron emission tomography in women with breast cancer Br J Surg 92 11 1363 1367 1:STN:280:DC%2BD2Mrntlequg%3D%3D 16187254
46. VW Lee EJ Sax DB McAneny S Pollack 1993 A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer J Nucl Med 34 12 2095 2100 1:STN:280:DyaK2c%2Fns1Smsw%3D%3D 8254394
47. CS Liu YY Shen CC Lin RF Yen CH Kao 2002 Clinical impact of [(18)F]FDG-PET in patients with suspected recurrent breast cancer based on asymptomatically elevated tumor marker serum levels: a preliminary report Jpn J Clin Oncol 32 7 244 247 12324574
48. TC McLoud PM Bourgouin RW Greenberg JP Kosiuk 1992 Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling Radiology 182 2 319 323 1:STN:280:DyaK387itlyksg%3D%3D 1732943
49. E Melani F Sardanelli C Ottonello RC Parodi 1995 Magnetic resonance mammography in suspected tumor recurrences Radiol Med (Torino) 89 3 219 224 1:STN:280:DyaK2M3ntlKrtg%3D%3D (article in Italian)
50. DH Moon J Maddahi DH Silverman JA Glaspy 1998 Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma J Nucl Med 39 3 431 435 1:STN:280:DyaK1c7ovVWgtA%3D%3D 9529287
51. LE Moses D Shapiro B Littenberg 1993 Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations Stat Med 12 14 1293 1316 1:STN:280: DyaK2c%2FitlGkug%3D%3D 8210827
52. E Moskovic S Curtis RP A'Hern CL Harmer 1992 The role of diagnostic CT scanning of the brachial plexus and axilla in the follow-up of patients with breast cancer Clin Oncol (R Coll Radiol) 4 2 74 77 1:STN:280: DyaK383gslyhsw%3D%3D
53. RD Muüller J Barkhausen W Sauerwein R Langer 1998 Assessment of local recurrence after breast-conserving therapy with MRI J Comput Assist Tomogr 22 3 408 412 9606381
54. Y Nomura S Tsutsui S Murakami Y Takenaka 1999 Prognostic impact of second cancer on the survival of early breast cancer patients Int J Oncol 14 6 1103 1109 1:STN:280:DyaK1M3nt1OrtA%3D%3D 10339665
55. SG Orel RH Troupin EA Patterson BL Fowble 1992 Breast cancer recurrence after lumpectomy and irradiation: role of mammography in detection Radiology 183 1 201 206 1:STN:280:DyaK387ps1aqsA%3D%3D 1312733
56. S Parker T Tong S Bolden PA Wingo 1997 Cancer statistics, 1997 CA Cancer J Clin 47 5 27 1:STN:280:DyaK2s7kvFalug%3D%3D 8996076
57. AP Pecking C Mechelany-Corone F Bertrand-Kermorgant JL Alberini 2001 Detection of occult disease in breast cancer using fluorodeoxyglucose camera-based positron emission tomography Clin Breast Cancer 2 3 229 234 1:STN:280:DC%2BD387mvVagtg%3D%3D 11899417
58. E Piperkova B Raphael ME Altinyay I Castellon 2007 Impact of PET/CT in comparison with same day contrast enhanced CT in breast cancer management Clin Nucl Med 32 6 429 434 17515747
59. Preda L, Villa G, Rizzo S, Bazzi L (2006) Magnetic resonance mammography in the evaluation of recurrence at the prior lumpectomy site after conservative surgery and radiotherapy. Breast Cancer Res 8(5):R53
60. A Qayyum AD MacVicar AR Padhani P Revell 2000 Symptomatic brachial plexopathy following treatment for breast cancer: utility of MR imaging with surface-coil techniques Radiology 214 3 837 842 1:STN:280:DC%2BD3c7osV2ntg%3D%3D 10715054
61. L Radan S Ben-Haim R Bar-Shalom L Guralnik 2006 The role of FDG-PET/CT in suspected recurrence of breast cancer Cancer 107 11 2545 2551 17063499
62. Z Rajkovaca G Vuleta A Matavulj P Kovacević 2007 99m Tc-sestamibi scintimammography in detection of recurrent breast cancer Bosn J Basic Med Sci 7 3 256 260 17848153
63. E Riebe K Günther K Schulz G Köhler 2007 Recurrent disease after breast preserving therapy (BPT) and radiation therapy for breast cancer-diagnostic yield of palpation, mammography and ultrasonography Ultraschall Med 28 4 394 400 1:STN:280:DC%2BD2svmtVCgsg%3D%3D 17610177
64. A Rieber E Merkle H Zeitler J Görich R Kreienberg 1997 Value of MR mammography in the detection and exclusion of recurrent breast carcinoma J Comput Assist Tomogr 21 5 780 784 1:STN:280:DyaK2svktValug%3D%3D 9294575
65. TJ Rissanen HP Mäkäräinen SI Mattila EL Lindholm 1993 Breast cancer recurrence after mastectomy: diagnosis with mammography and US Radiology 188 2 463 467 1:STN:280:DyaK3szhslyrsA%3D%3D 8327698
66. DL Sackett RB Haynes 2002 The architecture of diagnostic research BMJ 324 7336 539 541 1:STN:280:DC%2BD387jsleitg%3D%3D 11872558
67. GP Schmidt A Baur-Melnyk A Haug V Heinemann 2008 Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT Eur J Radiol 65 1 47 58 18082989
68. JH Shin BK Han YH Choe SJ Nam W Park 2005 Ultrasonographic detection of occult cancer in patients after surgical therapy for breast cancer J Ultrasound Med 24 5 643 649 15840796
69. W Siggelkow M Zimny A Faridi K Petzold 2003 The value of positron emission tomography in the follow-up for breast cancer Anticancer Res 23 2C 1859 1867 12820470 (Pubitemid 36750859)
70. Siggelkow W, Rath W, Buell U, Zimny M (2004) FDG PET and tumour markers in the diagnosis of recurrent and metastatic breast cancer. Eur J Nucl Med Mol Imag 31(Suppl 1):S118-S124
71. I Soerjomataram MW Louwman JG Ribot JA Roukema 2008 An overview of prognostic factors for long-term survivors of breast cancer Breast Cancer Res Treat 107 3 309 330 1:CAS:528:DC%2BD1cXht1Sgtrw%3D 17377838
72. PC Stomper A Recht AL Berenberg MS Jochelson 1987 Mammographic detection of recurrent cancer in the irradiated breast Am J Roentgenol 148 1 39 43 1:STN:280:DyaL2s%2FntlSlsw%3D%3D
73. M Stuhrmann R Aronius M Schietzel 2000 Tumor vascularity of breast lesions: potentials and limits of contrast-enhanced Doppler sonography Am J Roentgenol 175 6 1585 1589 1:STN:280:DC%2BD3M%2FnsFGnsw%3D%3D
74. M Suárez MJ Pérez-Castejón A Jiménez M Domper 2002 Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers Q J Nucl Med 46 2 113 121 12114874
75. M Tatsumi C Cohade KA Mourtzikos EK Fishman RL Wahl 2006 Initial experience with FDG-PET/CT in the evaluation of breast cancer Eur J Nucl Med Mol Imag 33 3 254 262 [Epub 2005 Oct 29]
76. F Ternier G Houvenaeghel F Lecrivain BL Brigand 2006 Computed tomography in suspected local breast cancer recurrence Breast Cancer Res Treat 100 3 247 254 1:STN:280:DC%2BD28nls12qsA%3D%3D 17033929
77. The GIVIO Investigators 1994 Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators JAMA 271 20 1587 1592
78. R Tiling I Khalkhali H Sommer R Linke 1998 Limited value of scintimammography and contrast-enhanced MRI in the evaluation of microcalcification detected by mammography Nucl Med Commun 19 1 55 62 1:STN:280:DyaK1c7nsFalug%3D%3D 9515547
79. J Tolmos JA Cutrone B Wang HI Vargas 1998 Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography J Natl Cancer Inst 90 11 846 849 1:STN:280:DyaK1c3os1ygtQ%3D%3D 9625173
80. S Usmani K Niaz Maseeh-Uz-Zaman K Niyaz 2007 Chest wall recurrence of breast cancer demonstrated on 99mTc-MIBI scintimammography Nucl Med Commun 28 11 842 846 17901766
81. D von Fournier H Anton H Junkermann G Bastert G van Kaick 1993 Breast cancer screening. State of the art and introduction to preventive measures Radiologe 33 227
82. IL Wapnir SJ Anderson EP Mamounas CE Geyer Jr 2006 Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials J Clin Oncol 24 13 2028 2037 16648502
83. WR Webb C Gatsonis EA Zerhouni RT Heelan 1991 CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group Radiology 178 3 705 713 1:STN:280:DyaK3M7jsVentA%3D%3D 1847239
84. L Weir D Worsley V Bernstein 2005 The value of FDG positron emission tomography in the management of patients with breast cancer Breast J 11 3 204 209 15871707
85. P Whiting AW Rutjes JB Reitsma PM Bossuyt 2003 The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews BMC Med Res Methodol 3 25 14606960
86. J Winehouse M Douek K Holz H Madjar 1999 Contrast-enhanced colour Doppler ultrasonography in suspected breast cancer recurrence Br J Surg 86 9 1198 1201 1:STN:280:DyaK1Mvjs1Kksw%3D%3D 10504377
87. RM Wolfort BD Li LW Johnson RH Turnage 2006 The role of whole-body fluorine-18-FDG positron emission tomography in the detection of recurrence in symptomatic patients with stages II and III breast cancer World J Surg 30 8 1422 1427 16715451
88. SK Yang N Cho WK Moon 2007 The role of PET/CT for evaluating breast cancer Korean J Radiol 8 5 429 437 17923786
89. MH Yilmaz G Esen Y Ayarcan 2007 The role of US and MR imaging in detecting local chest wall tumor recurrence after mastectomy Diagn Interv Radiol 13 13 18 17354188
90. J Zamora V Abraira A Muriel K Khan A Coomarasamy 2006 Meta-DiSc: a software for meta-analysis of test accuracy data BMC Med Res Methodol 6 31 16836745